种族对多囊卵巢综合征女性枸橼酸氯米芬促排卵结局的影响
这项回顾性队列研究纳入420例多囊卵巢综合征(PCOS)女性,比较北欧、地中海、非洲、东南亚和南美裔使用枸橼酸氯米芬促排卵的结局。不同种族间体重指数、腰围及血清LH、胰岛素和雄激素浓度存在差异,但枸橼酸氯米芬抵抗(CRA)患病率、最小有效剂量及预测排卵几率无显著差异。
要点
- 不同种族PCOS女性在体重指数(P=0.008)、腰围(P=0.036)及血清LH、胰岛素和雄激素浓度(均P<0.001)存在差异。
- 与北欧裔相比,其他种族枸橼酸氯米芬最小有效剂量无显著差异,CRA患病率相似(P=0.574)。
- 不同种族预测排卵几率无显著差异(P=0.504),但需更大队列验证。
核心结论
- 不同种族PCOS女性表型表达存在差异,但枸橼酸氯米芬抵抗性无排卵患病率、最小有效剂量及预测排卵几率未见显著差异。
- 作者指出需更大队列验证这些发现。
研究设计与样本
- 回顾性队列研究,纳入420例诊断为PCOS且开始枸橼酸氯米芬促排卵治疗的北欧、地中海、非洲、东南亚或南美裔女性。
- 所有女性按标准化方案接受枸橼酸氯米芬治疗,评估最小有效剂量和枸橼酸氯米芬抵抗(CRA)患病率,并预测排卵几率。
主要发现
- 不同种族PCOS女性体重指数差异P=0.008,腰围差异P=0.036,血清LH、胰岛素和雄激素浓度差异均P<0.001。
- 与北欧裔女性相比,其他种族女性枸橼酸氯米芬最小有效剂量无显著差异。
- CRA患病率在各种族间相似(P=0.574)。
- 不同种族预测排卵几率相似(P=0.504)。
局限性
- 作者指出需更大队列验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the influence of ethnicity on the outcome of ovulation induction with clomifene citrate in women with polycystic ovary syndrome (PCOS)? DESIGN: This was a retrospective cohort study. In total, 420 women diagnosed with PCOS who were of Northern European, Mediterranean, African, South-East Asian or South American descent, and who started ovulation induction treatment with clomifene citrate, were included. All women were treated with clomifene citrate according to a standardized treatment regimen. The minimal effective dose of clomifene citrate and prevalence of clomifene resistance (CRA) were assessed, and the chance of becoming ovulatory was predicted. RESULTS: Differences were observed in body mass index (P = 0.008), waist circumference (P = 0.036) and serum LH, insulin and androgen concentrations (all P < 0.001) in women of different ethnicities with PCOS. Compared with women of Northern European descent, the minimal effective dose of clomifene citrate in women of other ethnic groups was not significantly different. The prevalence of CRA (P = 0.574) was similar in all ethnic groups A similar chance of ovulation (P = 0.504) was predicted for the different ethnic groups. CONCLUSIONS: This is the first study aiming to link ethnicity to ovulation induction outcome in PCOS. Although women of different ethnicities who have PCOS exhibit a variation in phenotypic expression, there do not appear to be differences in the prevalence of clomifene-resistant anovulation or the minimal effective dose of clomifene citrate. Furthermore, a prediction model revealed no significant differences in the predicted chance of ovulation. A larger cohort is needed to validate these findings.
引用
- Meun C, Oostingh E, Louwers Y, et al. The influence of ethnicity on outcomes of ovulation induction with clomifene citrate in women with PCOS. Reprod Biomed Online. 2021. PMID: 35351379. doi:10.1016/j.rbmo.2021.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。